February 27 – 28, 2019
This week in San Francisco, thought leaders and practitioners in the pharma and biotech industries will gather at the Marines' Memorial Club & Hotel for the annual AI-PI: Drug Discovery Summit. Meet Data2Discovery there and hear “technical, data driven, case studies of real world implementation of AI within the drug discovery pipeline to address data quality, standardization and sharing challenges.”
Data2Discovery’s President, David Wild, will be speaking on day one of the conference with a talk on: Boosting Machine Learning with Knowledge Graphs & Node Embeddings. David will be presenting three use cases showing how knowledge graphs that integrate multiple datasets can create new insights and potentially significantly improve efficiency and effectiveness of drug discovery. See the latest from David and follow him on Twitter!
Data2Discovery will also be hosting a round table discussion, partnered with Open PHACTS, where we will be asking and answering an important question: what are the most effective ways pharmaceutical companies, AI and technology companies, and consortia can work together for mutual success?
Don’t miss David’s talk Wednesday, February 27th at 12:30PM and the Data2Discovery and Open PHACTS roundtable discussion that same day at 4PM. See the full agenda here.
Follow us on Twitter for industry news, conference updates, and more!
Data2Discovery is the global leader in applying knowledge graphs, AI & data science to drug discovery. With decades of experience and a platform that includes linked data, graph technologies, machine learning and artificial intelligence (AI), it is meeting the most important business challenges for the drug discovery industry.